Ip Clinic Sp. z o.o.

At Ip Clinic Sp. z o.o. in Lodz, research in gastroenterology focuses on inflammatory bowel disease and related digestive disorders, with studies in Crohn’s disease, ulcerative colitis, eosinophilic esophagitis, and gastroparesis. These trials are designed to test new treatments, improve symptom control, and better understand how to maintain remission and support long-term disease management.

• Testing new therapies for Crohn’s disease and ulcerative colitis
• Evaluating treatment options for eosinophilic esophagitis
• Studying approaches for idiopathic or diabetic gastroparesis

Much of the work is centered on helping patients with chronic digestive conditions achieve better control of inflammation and daily symptoms.

This site also contributes to research in immune-mediated diseases, especially conditions where the body’s immune response drives ongoing inflammation. The studies aim to evaluate whether new therapies can improve remission rates, reduce disease activity, and offer more durable control for patients living with chronic immune-related disorders.

• Investigating immune-targeted treatments for Crohn’s disease
• Assessing therapies for ulcerative colitis
• Exploring better ways to manage immune system diseases

The research reflects a strong focus on therapies that may help patients move beyond short-term relief toward sustained disease control.

Oncology trials at IP CLINIC cover several cancers, including non-small cell lung cancer, breast cancer, gastric and gastroesophageal junction cancer, and melanoma. These studies are mainly aimed at testing new treatment combinations, improving survival outcomes, and comparing emerging cancer therapies with current standards of care.

• Evaluating new approaches for advanced non-small cell lung cancer
• Studying treatment options for triple-negative breast cancer and early breast cancer
• Assessing therapies for gastric cancer and melanoma

The cancer portfolio shows a broad interest in both immunotherapy and combination treatment strategies across different tumor types.

Respiratory research at this clinical site includes studies in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, along with trials in lung cancer that involve the lungs and airways. The purpose is to evaluate new options that may improve breathing, slow disease progression, and support better outcomes for people with serious lung conditions.

• Testing treatments for COPD and chronic bronchitis
• Evaluating therapies for idiopathic pulmonary fibrosis
• Studying lung-focused cancer treatments in non-small cell lung cancer

These trials highlight a strong interest in both chronic respiratory disease management and advanced lung cancer care.

Research in skin and connective tissue diseases at Ip Clinic Sp. z o.o. includes studies in melanoma and allergic rhinitis/rhinoconjunctivitis-related conditions that affect the body’s response to environmental triggers. The trials are intended to assess new therapies, improve symptom relief, and support better care for patients with immune-related skin and tissue disorders.

• Investigating treatment options for melanoma
• Evaluating therapies for seasonal allergic rhinitis
• Exploring care improvements for rhinoconjunctivitis

Overall, the site’s work in this area connects dermatologic oncology with allergy-related research.